can.nab.is now
2017-03-23
DEA Approves Syndros® Cannabis Oral Solution as Schedule II
March 23, 2017— A new pharmaceutical drug produced by the company Insys has received approval for placement in Schedule II classification by the ...
read more
here
Delivered by @can_nab_is
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment